How many clinical trials are studying Sulfasalazine?

5 recruiting trials in our tracked data involve Sulfasalazine.

What conditions is Sulfasalazine being studied for?

In our tracked recruiting trials, Sulfasalazine is being studied in trials for Rheumatoid Arthritis, Colorectal cancer, Dyslipidaemia.

Sulfasalazine: clinical trials recruiting now

Q: Is Sulfasalazine FDA-approved?

Yes. According to the FDA drug label available through openFDA, Sulfasalazine is an FDA-approved drug.

Recruiting trials

Conditions studied

US states with sites

Countries

FDA drug label

FDA-approved: Yes. Sulfasalazine appears in the FDA drug-label database. Marketed as Sulfasalazine.
Drug class: Aminosalicylate (FDA established pharmacologic class)

FDA-approved use

Sulfasalazine Tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and b) for the prolongation of the remission period between acute attacks of ulcerative colitis.

FDA label via openFDA

Phase breakdown

Phase 1 2 Phase 2 2 Phase 3 2

Conditions being studied

Condition	Trials
Rheumatoid Arthritis	2
Colorectal cancer	1
Dyslipidaemia	1
Epilepsy	1
Glioblastoma	1
Lupus	1
Metastatic Colorectal Cancer	1
NASH	1
Non-alcoholic Fatty Liver Disease (NAFLD)	1
Psoriasis	1
Rheumatic Disease	1

Recruiting trials involving Sulfasalazine

Glutamate Inhibitors in Glioblastoma
NCT05664464 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
NCT07138898 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
Study of ECC4703 With Sulfasalazine and Pitavastatin
NCT07726368 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
Sulfasalazine in Patients With Metastatic Colorectal Cancer
NCT06134388 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
NCT03414502 · Phase: Phase 3 · Ages: 19 Years and older · Sex: All (male and female) · 1 location

Common questions

Is Sulfasalazine FDA-approved?

Yes, marketed as Sulfasalazine.

How many recruiting trials involve Sulfasalazine?

5 recruiting trials across 11 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.